BILLS-118hr6275ih.pdf

22:56 Nov 15 6275 IH 15 U.S.C. 45 2003 2023 30 days 3-year 5-year NOVEMBER 7 6275 IH Service later than 30 days 6275 IH SECTION 1 9 year 15 U.S.C. 12(a 180-DAY later than 6 years 2009 1ST SESSION H. R. 6275 42 U.S.C. 1-year 1112 6

the ‘‘Protecting Consumer 2 Access to

PO 00000 Frm PO 00000 Frm 00011 Fmt PO 00000 Frm 00007 PO 00000 Frm 00018 PO 00000 Frm 00010 PO 00000 Frm 00009 PO 00000 Frm 00008 PO 00000 Frm 00001 PO 00000 Frm 00020 PO 00000 Frm 00019 PO 00000 Frm 00016 PO 00000 Frm 00004 PO 00000 Frm 00015 PO 00000 Frm 00017 PO 00000 Frm 00006 PO 00000 Frm 00012

the United States the District of Columbia the United States Patent and Trade- United States the United States of America

NDA Commission U.S.C. the Federal Food, Drug SEC the Federal Trade Commission Act the Federal Trade Food and Drugs the Federal Trade Commission Federal the United States Court the Public Health Service Medicare Food, Drug FEDERAL TRADE COMMISSION RULEMAKING the Federal Food merce the Department of Justice the Committee on the Judiciary Federal Trade the Food and Drug Administration the Medicare Prescription Drug, Improvement sumer Access House of Representa- the Public Health Service Act GENERAL.—If Federal Regulations Consumer Access uct the Federal Trade Commis- the Committee on Energy Federal Food, Drug CONGRESS THE HOUSE OF REPRESENTATIVES Senate Biologics

DSKJM1Z7X2PROD CONNOLLY PEREZ SION CASTEN

generic patent manufacturers khammond bills bills khammond khammond federal trade covered product subsequent holder commission act trade commission product delay bio